Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 |
Human breast adenocarcinoma cell line | ATCC HTB-26 | Human | breast | cell line | adherent | plasmid | stable transfection | Metafectene | publication | Y. Radestock et al., Ann. N.Y. Acad Sci. 1041:462-469 (2005). Doi: 10.1196/annals.1282.070 | ||
MDA-MB-231 |
Human breast adenocarcinoma cell line | ATCC HTB-26 | Human | breast | cell line | adherent | plasmid | K2 Transfection System | publication | J. Arnold, et al., Journal of Experimental & Clinical Cancer Research, 2020, 39: 205, doi.org/10.1186/s13046-020-01712-w | Link | ||
MDA-MB-231 |
Human breast adenocarcinoma cell line | ATCC HTB-26 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | K. Wang et al., J. Biochem. Mol. Toxicol., 2018, e22039, doi.org/10.1002/jbt.22039 | ||
MDA-MB-231 |
Human breast adenocarcinoma cell line | ATCC HTB-26 | Human | breast | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | B. von Neubeck et al., Int. J. of Cancer, 2018, 143: 2065–2075, DOI: 10.1002/ijc.31607 | ||
MDA-MB-231 |
Human breast adenocarcinoma cell line | ATCC HTB-26 | Human | breast | cell line | adherent | plasmid | Metafectene PRO | publication | A. Ray et al., Mol. Cancer Res., Aug 2011; 9: 1030 - 1041 | Link | ||
MDA-MB-231 |
Human breast adenocarcinoma cell line | ATCC HTB-26 | Human | breast | cell line | adherent | siRNA | cotransfection (plasmid/siRNA) | Metafectene PRO | publication | S. Liu et al., J. Biol. Chem., 2015, 290(29): 17894-17908; DOI 10.1074/jbc.M114.607184 | Link | |
MDA-MB-231 |
Human breast adenocarcinoma cell line | ATCC HTB-26 | Human | breast | cell line | adherent | plasmid | Metafectene | publication | M. P.V. Shekhar et al., Mol. Cancer Res., Oct 2006; 4: 729 - 745 | Link | ||
MDA-MB-231 |
Human breast adenocarcinoma cell line | ATCC HTB-26 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M. M. Endres, Dissertation, 2016, Julius-Maximilians-Universität Würzburg | ||
MDA-MB-231 |
Human breast adenocarcinoma cell line | ATCC HTB-26 | Human | breast | cell line | adherent | plasmid | cotransfection (plasmid/siRNA) | Metafectene PRO | publication | S. Liu et al., J. Biol. Chem., 2015, 290(29): 17894-17908; DOI 10.1074/jbc.M114.607184 | Link | |
MDA-MB-231 |
Human breast adenocarcinoma cell line | ATCC HTB-26 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | J.-E. Lee et al., Journal of Proteomics, 2016, 131: 17-28; doi.org/10.1016/j.jprot.2015.10.005 | ||
MDA-MB-231 |
Human breast adenocarcinoma cell line | ATCC HTB-26 | Human | breast | cell line | adherent | plasmid | CRISPR | Metafectene PRO | publication | B. von Neubeck et al., Int. J. of Cancer, 2018, 143: 2065–2075, DOI: 10.1002/ijc.31607 | ||
MDA-MB-231 |
Human breast adenocarcinoma cell line | ATCC HTB-26 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | D. Konina et al., Int. J. Mol. Sci., 2021, 22, 8477, doi.org/10.3390/ijms22168477 | Link | |
MDA-MB-231 |
Human breast adenocarcinoma cell line | ATCC HTB-26 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M. Endres et al., Oncotarget, 2016, 7(39): 64244-64259 | Link | |
MDA-MB-435S |
Human breast cancer metastatic melanoma cell line | ATCC HTB-129 | Human | skin | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | I. Karwaciak et al., Cancers, 2019, 11, 673, doi:10.3390/cancers11050673 | Link | |
MDA-MB-435S |
Human breast cancer metastatic melanoma cell line | ATCC HTB-129 | Human | skin | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | I. Karwaciak et al., Cancers, 2019, 11, 673, doi:10.3390/cancers11050673 | Link | |
MDA-MB-435S |
Human breast cancer cell line | ATCC HTB-129 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | K. Kemppainen et al., Cellular Signalling, 2016, 28: 1894–1903; doi.org/10.1016/j.cellsig.2016.09.004 | ||
MDA-MB-436 |
Human breast cancer cell line | Human | breast | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | L. J. Barlow, Dissertation, 2020, University Graduate School | Link | ||
MDA-MB-436 |
Human breast cancer cell line | Human | breast | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | L. J. Barlow, Dissertation, 2020, University Graduate School | Link | ||
MDA-MB-468 |
Human breast adenocarcinoma cell line | ATCC HTB-132 | Human | breast | cell line | adherent | oligonucleotide | DOTAP | publication | A. Avinó et al., Protocols in Nucleic Acid Chemistry, 2020, 77: e78, doi: 10.1002/cpnc.78 | |||
MDA-MB-468 |
Human breast adenocarcinoma cell line | ATCC HTB-132 | Human | breast | cell line | adherent | plasmid | Metafectene PRO | publication | A. Ray et al., Mol. Cancer Res., Aug 2011; 9: 1030 - 1041 | Link | ||
ME-180 |
Human papillomavirus-related cervical squamous cell carcinoma cell line | ATCC HTB-33 | Human | genital tract | cell line | adherent | plasmid | Metafectene | publication | E. Xu et al., Mol. Cancer Res., 2014, 12(3):359-369, DOI: 10.1158/1541-7786.MCR-13-0526 | Link | ||
Me14346ADH |
Human melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | A.Tuccitto et al., STEM CELLS, 2016, 34:2449-2460; doi.org/10.1002/stem.2413 | Link | ||
Me15888S |
Human melanoma cell line | Human | skin | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | A.Tuccitto et al., STEM CELLS, 2016, 34:2449-2460; doi.org/10.1002/stem.2413 | Link | ||
Me15888S |
Human melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | A.Tuccitto et al., STEM CELLS, 2016, 34:2449-2460; doi.org/10.1002/stem.2413 | Link | ||
MEC-2 |
Human chronic B cell leukemia cell line | DSMZ ACC500 | Human | immune system | cell line | suspension | siRNA | RNA-Interference | Metafectene PRO | publication | S. W. Hofbauer et al., Cancer Res., Sep 2010; 70: 7336 - 7344 | Link |